News - Savient Pharmaceuticals

Filter

Current filters:

Savient Pharmaceuticals

Popular Filters

Savient files for voluntary bankruptcy protection; plans asset sale

15-10-2013

US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

SOBI links with Savient for co-promotion of Kineret in USA

19-02-2013

Swedish Orphan Biovitrum (STO: SOBI) says it has entered into an agreement with USA-based Savient Pharmaceuticals…

Anti-Arthritics/RheumaticsInflammatory diseasesKineretLicensingMarkets & MarketingNorth AmericaPharmaceuticalSavient PharmaceuticalsSobiSwedish Orphan Biovitrum

Savient's Krystexxa gets final EU approval for chronic tophaceous gout

10-01-2013

US drugmaker Savient Pharmaceuticals (Nasdaq: SVNT) says that the European Commission has granted a marketing…

EuropeInflammatory diseasesKrystexxaPharmaceuticalRegulationSavient Pharmaceuticals

Chelsea Therapeutics and Savient to slash jobs

11-07-2012

Chelsea Therapeutics International (Nasdaq: CHTP) yesterday announced restructuring plans to "significantly…

BiotechnologyChelsea TherapeuticsFinancialKrystexxaManagementNortheraSavient Pharmaceuticals

Allopurinol remains gout market leader but Uloric making inroads, study finds

18-04-2012

Most surveyed rheumatologists, nephrologists and primary care physicians cite increased use of Takeda's…

allopurinolAnti-Arthritics/RheumaticsGenito-urinaryKrystexxaMarkets & MarketingPharmaceuticalSavient PharmaceuticalsTakeda PharmaceuticalsUloric

Several abstracts on gout reveal true burden of disease and highlight promising new treatments

27-05-2011

New studies on gout were presented this week at EULAR, the Annual Congress of the European League Against…

allopurinolAnti-Arthritics/RheumaticsKrystexxalesinuradPharmaceuticalRegulationResearchSavient Pharmaceuticals

EC approves Pfizer’s Revatio for PAH in children; Savient files Krystexxa with EMA

06-05-2011

US drugs behemoth Pfizer (NYSE: PFE) yesterday revealed that Revatio (sildenafil citrate, which is also…

Anti-Arthritics/RheumaticsCardio-vascularEuropeKrystexxaPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatioSavient Pharmaceuticals

Back to top